Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review
Manasvi Singh(Bennett University), Seemant Chaturvedi(University of Iowa), Deepak L. Bhatt(Brigham and Women's Hospital), Inderpal Singh, Kosmas I. Paraskevas, Zoltán Ruzsa, Ashish Kumar(Bennett University), Narpinder Singh(Graphic Era University), Laura E. Mantella(University of Toronto), Mostafa M. Fouda(Idaho State University), Mustafa Al-Maini, Deepak Garg, Aditya Sharma(University of Manitoba), Jagjit S. Teji(Lurie Children's Hospital), Narendra N. Khanna, Luca Saba(Azienda Ospedaliero-Universitaria Cagliari), José Fernandes e Fernandes(University of Lisbon), Gavino Faa(University of Cagliari), Vijay Rathore(Kaiser Permanente), Dimitri P. Mikhailidis(The Royal Free Hospital), Andrew F. Laine(Columbia University), John R. Laird(St. Helena Hospital), Andrew Nicolaides(University of Nicosia), Amer M. Johri(Queen's University), Kalyan Tadepalli(Centre for Artificial Intelligence and Robotics), Rajesh Singh(Uttaranchal University), Esma R. Isenovic(University of Belgrade), Vijay Viswanathan(M.V. Hospital for Diabetes and Diabetes Research Centre), George D. Kitas(Dudley Group NHS Foundation Trust), Manudeep K. Kalra(Harvard University)
Cited by 137
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k